- Display 15 Products per page
Published: August 22, 2022 | Price: $0.00 – $10,000.00
The search for the next large-scale emerging disease was on before the COVID-19 pandemic. Respiratory diseases were among those suggested by Kalorama Information and other outlets and medical associations as possibilities for the next threat. The search is constant, and is by no means limited to respiratory epidemics. As the recent monkeypox concern has demonstrated, little-known pathogens can emerge and become large health threats. This necessitates the development of tests at laboratories. For business planners, it’s worthwhile to have a...Published: April 7, 2022 | Price: $6,000.00 – $12,000.00
The Most Comprehensive and Reliable Market Sizing and Forecasts in Infectious Disease IVD [caption id="attachment_18836" align="aligncenter" width="300"] Attend a WEBINAR on this topic.[/caption] Infectious disease testing comprises one of the largest and fastest growing applications served by the global in vitro diagnostics (IVD) industry. Infectious diseases are ailments caused by pathogenic microorganisms that invade the body, either directly or indirectly via afflicted carriers or contaminated sources. IVD tests for these conditions are designed to detect and identify the...Published: May 27, 2020 | Price: $3,000.00 – $6,000.00
In light of the COVID-19 (coronavirus) pandemic, it is extremely timely to present a report on the status quo in emerging infectious diseases. While the current pandemic is troublesome and has disrupted normal life, it will follow its course and then fade away. Where could the next pandemic or epidemic come from? There are a number of diseases currently tracking as moving from the developed world to the developing world? Kalorama has addressed emerging infectious disease since our first study nine...Published: April 7, 2020 | Price: $4,000.00 – $8,000.00
The past few years has seen extraordinary advances in artificial intelligence (AI) in clinical medicine. More products have been cleared for clinical use, more new research-use-only applications have come to market and many more are in development. In recent years, diagnostics companies – in collaboration with AI companies – have begun implementing increasingly sophisticated machine learning techniques to improve the power of data analysis for patient care. The goal is to use developed algorithms to standardize and aid interpretation of...Published: October 31, 2019 | Price: $3,000.00 – $6,000.00
This report is an update on the worldwide in vitro diagnostics (IVD) market, examining several of the factors that currently contribute to the evolving IVD market picture. The topics discussed are the following: The Worldwide IVD Market, 2019-2024 Market Developments in Selected Markets – North America, EU15/Western Europe, Eastern Europe, Japan and China Genetic Testing New POC Innovations Cancer Testing and Personalized Medicine Hematology Glucose Monitoring Advancements HbA1c Testing New Developments in Infectious Diseases Cytology - Increasing Molecular Dx Options...Published: October 11, 2019 | Price: $5,000.00 – $10,000.00
In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in Kalorama’s IVD Test Procedure Volumes, 2019-2024 saves time with calculations and estimates of the both the existing number of procedures for scores of diagnostic tests, and the future potential. In the process, pricing analysis is also performed. This report is an essential resource for the IVD...Published: July 23, 2019 | Price: $4,500.00 – $9,000.00
Over half of the revenues earned in molecular diagnostics are earned by companies marketing tests to detect infectious disease. This Kalorama Information report examines the market opportunity for those tests, the companies that sell them, trends in the market and details segment-level market sizing and forecasts. Test Segments: Market Sizing and Forecasts There are several segments where testing at the molecular level has thrived, including the following: • HPV Testing • CT/NG Testing • Molecular Hepatitis Testing • HIV Testing...Published: April 30, 2019 | Price: $5,500.00 – $11,000.00
Infectious disease testing comprises one of the largest and fastest growing applications served by the global in vitro diagnostics (IVD) industry. Most of the leading industry competitors as well as a sizable number of specialized IVD concerns are active in this product segment. The detection and characterization of infectious diseases hold promising worldwide growth potential as discussed in Kalorama’s Infectious Disease Diagnostics: World Market Analysis: HIV/AIDS, Hepatitis, Tuberculosis, STDs, HAIs, ID/AST, Influenza, TORCH, Other. The World Infectious Disease Testing Market...Published: March 8, 2019 | Price: $5,000.00 – $10,000.00
Clinical laboratories are an essential part of the health industry. It is estimated that between 70% - 80% of physicians’ diagnoses are a result of laboratory tests. In addition to diagnosing patients, clinical lab testing is performed to evaluate disease progression, monitor drug treatment and conditions, determine individual therapy, and several other reasons. Clinical Laboratory Services Market provides an overview of the clinical laboratory industry and the trends driving growth. Included in the report are statistics influencing the industry, incidence...Published: March 22, 2018 | Price: $2,995.00 – $5,995.00
This Kalorama Information report, Point of Care Infectious Disease Diagnostic Testing provides market sizing and forecasts for the following disease areas Influenza STD HIV Hepatitis Malaria C. difficile E. coli H. pylori Home Test/OTC Others Point of care testing market features competitors that are large major concerns as well as newer entrants and specialist players. As part of its coverage, the report also profiles competitors in the market, including the following: Abbott/Alere Atlas Genetics Ltd. Atlas Link Biotech Co., Ltd...Published: October 1, 2011 | Price: $150.00 – $300.00
The World Health Organization has identified a group of diseases that are the world's most pressing health problems. This represents an opportunity for test manufacturers, particularly in POC testing. Because of their ability to deliver fast results at the point of care, rapid testing is a focus area of healthcare providers and payors in infectious disease prevention. Kalorama Information has been reporting on the rapid test area for several years and has identified the segments with the fastest growth, and...Published: July 1, 2011 | Price: $150.00 – $300.00
A hospital-acquired infection (HAI)is a new infection that develops in a patient during hospitalization. It is usually defined as an infection that is identified at least forty-eight to seventy-two hours following admission, so infections incubating, but not clinically apparent, at admission are excluded. This type of infection is also known as a nosocomial infection (or more generically healthcare-associated infections). The industry has responded with a variety of testing and treatment products. This report, Hospital-Acquired Infections: Diagnostic Markets and Testing Developments,...Published: May 1, 2009 | Price: $250.00 – $1,600.00
The outbreak of H1N1 (swine flu) highlighted the public health importance of improved testing techniques and providing market opportunities for manufacturers of diagnostic tests and other products related to the disease. These conclusions and others appear in a new report released from Kalorama Information: Swine Flu Market Alert by Kalorama's lead analyst, Shara Rosen. Regardless of the eventual severity of the epidemic, there will be distinct market impact on both immunoassay and molecular test makers, according to the report. The...Published: August 1, 2008 | Price: $1,500.00 – $7,000.00
Test services, once the norm in the diagnostics industry, then abandoned for reagent sales, are now making a comeback. IVD companies have established cGMP and CLIA-registered labs by which they offer their proprietary tests to physicians, hospitals and reference labs. These tests are outside the oversight of the traditional FDA and CE Mark test commercialization avenue in the U.S, and Europe and so are thought to come to market by what may seem to be the back door. Kalorama has...Published: October 1, 2004 | Price: $995.00 – $1,990.00
Currently, the largest market application segment for molecular diagnostics is that for infectious disease testing. The segment is expected to grow at an annual rate between 7% and 8% over the next few years will present some excellent market opportunites for molecular diagnostic competitors. This summary report, extracted from Kalorama Information’s U.S. Market for Molecular Diagnostics, (2nd Edition, May 2004), focuses on the technologies and application of molecular diagnostics in the field of infectious disease testing. The major market effects...